Neurologic disease associated with 17D-204 yellow fever vaccination: A report of 15 cases
- 27 November 2006
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 25 (10), 1727-1734
- https://doi.org/10.1016/j.vaccine.2006.11.027
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Yellow fever and Japanese encephalitis vaccines: indications and complicationsInfectious Disease Clinics of North America, 2005
- Yellow fever vaccine: An updated assessment of advanced age as a risk factor for serious adverse eventsVaccine, 2005
- Viscerotropic and neurotropic disease following vaccination with the 17D yellow fever vaccine, ARILVAX®Vaccine, 2004
- First recorded outbreak of yellow fever in Kenya, 1992-1993. I. Epidemiologic investigations.The American Journal of Tropical Medicine and Hygiene, 1998
- Clinical and Epidemiologic Features of Guillain‐Barré SyndromeThe Journal of Infectious Diseases, 1997
- An Epidemic of Sylvatic Yellow Fever in the Southeast Region of Maranhao State, Brazil, 1993–1994: Epidemiologic and Entomologic FindingsThe American Journal of Tropical Medicine and Hygiene, 1997
- EPIDEMIC YELLOW FEVER IN EASTERN NIGERIA, 1986The Lancet, 1988
- Epidemiology of Central Nervous System Infections in Olmsted County, Minnesota, 1950-1981The Journal of Infectious Diseases, 1986
- Encephalitis and aseptic meningitis, Olmsted County, Minnesota, 1950–1981: I. EpidemiologyAnnals of Neurology, 1984
- Encephalitis following neurotropic yellow fever vaccine administered by scarification in Nigeria: Epidemiological and laboratory studiesTransactions of the Royal Society of Tropical Medicine and Hygiene, 1955